Mental Health Startup Journey Colab Aims To Develop Mescaline As An FDA-Approved Treatment For Alcohol Use Disorder Journey Colab will test mescaline, a long-acting psychedelic found in peyote, as an adjuvant to conventional treatments for alcohol use disorder.  It gives co-founder equity to the Indigenous communities that inspire its work.